Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 11,881–11,900 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

NA ASCORBATE 500MG/ML (PF), In a) 10ML Vials, b) 50ML Vials, and c) 100ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

MOLYBDENUM 250MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

M.I.C 25/50/50 W/METHYL B12 1MG/PYRIDOXAL 50MG/ML (PF), 1ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

M.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%) B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-50MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

M.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 1MG; B1 0.833MG; B2 0.083MG; B3 0.833MG, B5 0.083MG, B6 0.083MG, CYANO B12 1.66MCG, METHIONINE 0.208MG, INOSITOL 0.416MG, CHOLINE CL 1.66MG/ML, 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

M.I.C./B-COMPLEX (PF) B1-50MG;B2-5-PO4-5MG;B3-50MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-5MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

M.I.C. 25/50/50 (PF) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL B12 10MG/ML W/PRES (BENZALKONIUM 0.01%) IN NACL 0.9%, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL B12 5MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL B12 1000MCG/ML/PYRIDOXINE 100MG W/PRES. (BENZALKONIUM 0.01%), In a) 1ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01% IN NACL 0.9%, In a) 2ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

MANGANESE CHL 0.1MG/ML PF, 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

LIPO-INJECTION W/LIDOCAINE NO METHIONINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG,INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.